Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls
Description
Patients with multiple myeloma are at high risk of severe forms of COVID-19. Despite data showing diminished response to vaccine, the era of highly efficient mRNA vaccine might be a gamechanger. We sought to examine response to mRNA vaccine between